InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Crowley Elizabeth, Vice-Présidente Senior et Responsable de la Conformité des Produits. Insider active across 1 company, notably Celldex Therapeutics, Inc.. Cumulatively, 5 disclosures have been published. History available since 1 November 2021. The latest transaction was filed on 14 June 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Elizabeth Crowley serves as Senior Vice President and Chief Product Development Officer at Celldex Therapeutics, Inc. She is responsible for ensuring that the company's products meet regulatory standards. Her expertise is essential in ensuring the safety and efficacy of the products.